ArticleFrontiers in cellular and infection microbiology2023

End-of-treatment anti-HBs levels and HBeAg status identify durability of HBsAg loss after PEG-IFN discontinuation.

Yifei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.